Amicus Therapeutics, Inc.'s (FOLD) CEO John Crowley on Q1 2022 Results - Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:NASDAQ:FOLD) Q1 2022 Earnings Conference Call May 09, 2022, 08:30 AM ET Company Participants Andrew Faughnan - Executive Director-Investor Relations John...

Related Keywords

Germany ,Japan ,Yun Zhong ,Shanxi ,China ,Shanghai ,United States ,Wuxi ,Jiangsu ,United Kingdom ,Argentina ,Brazil ,Chile ,Colombia ,United Arab Emirates ,Turkey ,Gulf States ,American ,Kristen Kluska ,Andrew Faughnan ,Mitchell Goldman ,Anupam Rama ,Jeff Castelli ,Ellie Merle ,Beth Feindt Scott ,Bradley Campbell ,Jeffrey Castelli ,Asia Pacific ,John Crowley ,Joe Schwartz ,Salveen Richter ,Daphne Quimi ,Development Officer ,Company Participants ,Goldman Sachs ,Amicus Therapeutics Inc ,Nasdaq ,Exchange Commission ,Cantor Fitzgerald ,European Medicines Agency ,Amicus Therapeutics ,Conference Call May ,Chief Executive ,Chief Operating ,Amicus Therapeutic First Quarter ,Results Conference Call ,Executive Director ,Amicus Therapeutic ,Chief Executive Officer ,Chief Operating Officer ,Chief Financial Officer ,Chief Development ,Chief Medical Officer ,Chief Business ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Pompe Disease ,Latin American ,Middle East ,North Africa ,Chief Development Officer ,Scientific Conference ,Early Access ,Medicine Scheme ,Lancet Neurology ,Wuxi Biologics ,Ritu Baral ,Wuxi City ,Thanks Ellie ,Early Access Medicine Scheme ,Lysosomal Storage ,Dae Gon ,Patient Assistance ,